Be Biosol Private Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. 4, Sy No. 542/P, Biotech Park, Phase II, Kolthur Village, Shamirpet Mandal, Medchal-Malkajgiri, Telangana 500078, India (IND)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3008377265 · DUNS 871410645
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-11-12
- VAIDrug Quality Assurance2024-04-26
- VAIDrug Quality Assurance2019-08-02
Drugs this plant is listed as making
8 distinct drugs across 19 products name this site in their FDA label.
- daptomycinBE Pharmaceuticals Inc.
- enoxaparin sodiumBE Pharmaceuticals Inc.
- fosaprepitantBE Pharmaceuticals Inc.
- Heparin Sodiumin shortageBE Pharmaceuticals Inc.
- neostigmine methylsulfateCamber Pharmaceuticals Inc.
- Sodium NitroprussideBE Pharmaceuticals Inc.
- Succinylcholine ChlorideBE Pharmaceuticals Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.